Quaderi, S. A., & Hurst, J. R. (2018). The unmet global burden of COPD. Glob Health Epidemiol Genom, 3, e4.
Article CAS PubMed PubMed Central Google Scholar
Garcia-Gordillo, M., Collado-Mateo, D., Olivares, P. R., Adsuar, J. C., & Merellano-Navarro, E. (2017). A cross-sectional Assessment of Health-related quality of life among patients with chronic obstructive Pulmonary Disease. Iran J Public Health, 46(8), 1046–1053.
PubMed PubMed Central Google Scholar
Currow, D. C., Chang, S., Grande, E. D., Ferreira, D. H., Kochovska, S., Kinchin, I., Johnson, M. J., & Ekstrom, M. (2020). Quality of life changes with duration of chronic breathlessness: A Random Sample of Community-Dwelling people. J Pain Symptom Manage, 60(4), 818–827e4.
Lin, F. J., Pickard, A. S., Krishnan, J. A., Joo, M. J., Au, D. H., Carson, S. S., Gillespie, S., Henderson, A. G., Lindenauer, P. K., McBurnie, M. A., Mularski, R. A., Naureckas, E. T., Vollmer, W. M., & Lee, T. A. (2014). Measuring health-related quality of life in chronic obstructive pulmonary disease: Properties of the EQ-5D-5L and PROMIS-43 short form. Bmc Medical Research Methodology, 14, 78.
Article PubMed PubMed Central Google Scholar
Maqhuzu, P. N., Szentes, B. L., Kreuter, M., Bahmer, T., Kahn, N., Claussen, M., Holle, R., & Schwarzkopf, L. (2020). Determinants of health-related quality of life decline in interstitial lung disease. Health and Quality of Life Outcomes, 18(1), 334.
Article PubMed PubMed Central Google Scholar
Whalley, D., Globe, G., Crawford, R., Doward, L., Tafesse, E., Brazier, J., & Price, D. (2018). Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective. Health and Quality of Life Outcomes, 16(1): p. 160.
Simon Pickard, A., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536.
Nolan, C. M., Longworth, L., Lord, J., Canavan, J. L., Jones, S. E., Kon, S. S., & Man, W. D. (2016). The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax, 71(6), 493–500.
Sullivan, P. W., Ghushchyan, V. H., Campbell, J. D., Globe, G., Bender, B., & Magid, D. J. (2016). Measurement of utility in asthma: Evidence indicating that generic instruments may miss clinically important changes. Quality of Life Research, 25, 3017–3026.
Petrillo, J., van Nooten, F., & Jones, P. (2011). Rutten-Van Mölken, Utility estimation in chronic obstructive pulmonary disease: A preference for change?. Pharmacoeconomics, 29, 917–932.
Krabbe, P. F., Stouthard, M. E., Essink-Bot, M. L., & Bonsel, G. J. (1999). The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. Journal of Clinical Epidemiology, 52(4), 293–301.
Article CAS PubMed Google Scholar
Luo, N., Wang, X., Ang, M., Finkelstein, E. A., Aung, T., Wong, T. Y., & Lamoureux, E. (2015). A Vision Bolt-On Item could increase the discriminatory power of the EQ-5D index score. Value in Health, 18(8), 1037–1042.
Swinburn, P., Lloyd, A., Boye, K. S., Edson-Heredia, E., Bowman, L., & Janssen, B. (2013). Development of a Disease-Specific Version of the EQ-5D-5L for use in patients suffering from Psoriasis: Lessons learned from a feasibility study in the UK. Value in Health, 16(8), 1156–1162.
Wolfs, C. A., Dirksen, C. D., Kessels, A., Willems, D. C., Verhey, F. R., & Severens, J. L. (2007). Performance of the EQ-5D and the EQ-5D + C in elderly patients with cognitive impairments. Health and Quality of life Outcomes, 5(1), 1–10.
Geraerds, A., Bonsel, G. J., Janssen, M. F., Finch, A. P., Polinder, S., & Haagsma, J. A. (2021). Methods used to identify, test, and assess impact on preferences of Bolt-Ons: A systematic review. Value In Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(6), 901–916.
Mulhern, B. J., Sampson, C., Haywood, P., Addo, R., Page, K., Mott, D., Shah, K., Janssen, M. F., & Herdman, M. (2022). Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons. Quality of Life Research, 31(10), 3041–3048.
Article PubMed PubMed Central Google Scholar
Longworth, L., Yang, Y., Young, T., Mulhern, B., Hernández Alava, M., Mukuria, C., Rowen, D., Tosh, J., Tsuchiya, A., & Evans, P. (2014). Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: A systematic review, statistical modelling and survey. Health Technology Assessment.
Geraerds, A., Bonsel, G. J., Polinder, S., Panneman, M. J. M., Janssen, M. F., & Haagsma, J. A. (2020). Does the EQ-5D-5L benefit from extension with a cognitive domain: Testing a multi-criteria psychometric strategy in trauma patients. Quality of Life Research, 29(9), 2541–2551.
Article CAS PubMed PubMed Central Google Scholar
Hoogendoorn, M., Oppe, M., Boland, M. R. S., Goossens, L. M. A., & Stolk, E. A. (2019). Rutten–Van Mölken, exploring the impact of adding a respiratory dimension to the EQ-5D-5L. Medical Decision Making, 39(4), 393–404.
Article PubMed PubMed Central Google Scholar
Hoogendoorn, M., Jowett, S., Dickens, A. P., Jordan, R., Enocson, A., Adab, P., & Versteegh, M. (2021). -v. Mölken, performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study. Value in Health, 24(11), 1667–1675.
Australian Bureau of Statistics (ABS): 2016 Census: Australian Bureau of Statistics. https://www.abs.gov.au/websitedbs/censushome.nsf/home/2016(Last Accessed March 16, (2020).
Bestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54(7), 581–586.
Article CAS PubMed PubMed Central Google Scholar
Ustun, T. B., Kostanjesek, N., Chatterji, S., Rehm, J., & Organization, W. H. (2010). Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0) / edited by T.B. Üstün, N. Kostanjsek, S. Chatterji, J.Rehm. World Health Organization: Geneva.
Zacarias, L. C., Câmara, K. J. C., Alves, B. M., Morano, M. T. A. P., Viana, C. M. S., Mont’Alverne, D. G. B., Castro, S. S., & Leite, C. F. (2022). Validation of the World Health Organization Disability Assessment Schedule (WHODAS 2.0) for individuals with COPD. Disability and Rehabilitation, 44(19), 5663–5668.
Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., Del Prete, A., Cesana, G., & Mantovani, L. G. (2013). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.
Cohen, J. (1992). A power primer. Psychological Bulletin, 112(1), 155–159.
Article CAS PubMed Google Scholar
Ishii, Y. (2013). [Smoking and respiratory diseases]. Nihon rinsho. Japanese Journal of Clinical Medicine, 71(3), 416–420.
Cohen, J. (1969). Statistical Power Analysis for the behavioral sciences. NY Academic.
de Graaf, J. A., Kuijpers, M., Visser-Meily, J., Kappelle, L. J., & Post, M. (2020). Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke. Clinical Rehabilitation, 34(4), 545–550.
Krabbe, P. F. M., Stouthard, M. E. A., Essink-Bot, M. L., & Bonsel, G. J. (1999). The Effect of adding a cognitive dimension to the EuroQol Multiattribute Health-Status classification system. Journal of Clinical Epidemiology, 52(4), 293–301.
Article CAS PubMed Google Scholar
Yang, Y., Rowen, D., Brazier, J., Tsuchiya, A., Young, T., & Longworth, L. (2015). An exploratory study to test the impact on three bolt-on items to the EQ-5D. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 18(1), 52–60.
Esquinas, C., Ramon, M. A., Nuñez, A., Molina, J., Quintano, J. A., Roman-Rodríguez, M., Naberan, K., Llor, C., Roncero, C., Miravitlles, M., & Barrecheguren, M. (2020). Correlation between disease severity factors and EQ-5D utilities in chronic obstructive pulmonary disease. Quality of Life Research, 29(3), 607–617.
Comments (0)